Pinotbio
PrivateLast Round
VC Round
Oct 27, 2025
Est. Valuation
$79.55M
Total Funding Raised
$31.8M
Company Overview
Pinotbio is a biotechnology company that develops novel anticancer therapeutics and antibody-drug conjugate (ADC) platform technologies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
antibody-drug conjugateADCanticancer therapeuticsbiotechnology licensingtargeted therapycamptothecindrug discoveryoncology researchlinker technologybiotech platformprecision medicineclinical-stage biotechdrug resistancepayload technologybiopharma partnering
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Pinotbio Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Pinotbio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Oct 27, 2025 | ||||
| VC Round | Apr 21, 2023 | ||||
| Strategic | Oct 18, 2022 | ||||
| Strategic | Mar 22, 2021 | ||||
| Series C | Nov 9, 2020 | ||||
Series B | Nov 20, 2019 |
Pinotbio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| BNH INVESTMENT | VC Round |
| I-ON Asset Management | Series C |
| KB Investment | VC Round, Series B |
| Ulmus Investment | Series C |
| Company K Partners | Series A, Seed |
| Stonebridge Ventures | Series B |
| KB Securities | Series C |
Pinotbio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Pinotbio's valuation, stock price, and market status.
Firmographic Details
HeadquartersSouth Korea
Employee Range5
Year Founded2017
Last FundingOct 27, 2025